{"name":"ModernaTX, Inc.","slug":"modernatx-inc","ticker":"","exchange":"","domain":"modernatx.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":51,"colorKey":"oncology","drugs":[{"name":"Fluarix Quadrivalent","genericName":"Fluarix Quadrivalent","slug":"fluarix-quadrivalent","indication":"Other","status":"marketed"},{"name":"Influenza Vaccine 2","genericName":"Influenza Vaccine 2","slug":"influenza-vaccine-2","indication":"Other","status":"marketed"},{"name":"SoC Treatment","genericName":"SoC Treatment","slug":"soc-treatment","indication":"Other","status":"phase_1"},{"name":"Adjuvanted Quadrivalent Influenza Vaccine","genericName":"Adjuvanted Quadrivalent Influenza Vaccine","slug":"adjuvanted-quadrivalent-influenza-vaccine","indication":"Prevention of influenza disease caused by four different strains of the influenza virus","status":"phase_2"},{"name":"Afluria® Quadrivalent","genericName":"Afluria® Quadrivalent","slug":"afluria-quadrivalent","indication":"Seasonal influenza prevention in adults and children ≥6 months of age","status":"phase_3"},{"name":"Egg-based Quadrivalent Influenza Vaccine","genericName":"Egg-based Quadrivalent Influenza Vaccine","slug":"egg-based-quadrivalent-influenza-vaccine","indication":"Other","status":"phase_2"},{"name":"Influenza Vaccine 1","genericName":"Influenza Vaccine 1","slug":"influenza-vaccine-1","indication":"Other","status":"phase_1"},{"name":"Investigational COVID-19 Vaccine 2","genericName":"Investigational COVID-19 Vaccine 2","slug":"investigational-covid-19-vaccine-2","indication":"Other","status":"phase_1"},{"name":"Investigational COVID-19 Vaccine Lot A","genericName":"Investigational COVID-19 Vaccine Lot A","slug":"investigational-covid-19-vaccine-lot-a","indication":"Other","status":"phase_2"},{"name":"Investigational COVID-19 Vaccine Lot B","genericName":"Investigational COVID-19 Vaccine Lot B","slug":"investigational-covid-19-vaccine-lot-b","indication":"Other","status":"phase_2"},{"name":"Investigational Influenza Vaccine 1","genericName":"Investigational Influenza Vaccine 1","slug":"investigational-influenza-vaccine-1","indication":"Other","status":"phase_1"},{"name":"SPIKEVAX X","genericName":"SPIKEVAX X","slug":"spikevax-x","indication":"Other","status":"phase_2"},{"name":"mRNA-1018 for H5N8","genericName":"mRNA-1018 for H5N8","slug":"mrna-1018-for-h5n8","indication":"Other","status":"phase_1"},{"name":"mRNA-1018 for H7 Only","genericName":"mRNA-1018 for H7 Only","slug":"mrna-1018-for-h7-only","indication":"Other","status":"phase_1"},{"name":"mRNA-1083 Composition 1 Dose C","genericName":"mRNA-1083 Composition 1 Dose C","slug":"mrna-1083-composition-1-dose-c","indication":"Other","status":"phase_2"},{"name":"mRNA-1195","genericName":"mRNA-1195","slug":"mrna-1195","indication":"Other","status":"phase_2"},{"name":"mRNA-1273.231","genericName":"mRNA-1273.231","slug":"mrna-1273-231","indication":"Other","status":"phase_2"},{"name":"mRNA-1647","genericName":"mRNA-1647","slug":"mrna-1647","indication":"Other","status":"phase_3"},{"name":"mRNA-1769","genericName":"mRNA-1769","slug":"mrna-1769","indication":"Other","status":"phase_1"},{"name":"mRNA-2752","genericName":"mRNA-2752","slug":"mrna-2752","indication":"Other","status":"phase_1"},{"name":"Alpharix® Tetra","genericName":"Alpharix® Tetra","slug":"alpharix-tetra","indication":"Indication under investigation in Phase 3 (specific indication not publicly disclosed)","status":"phase_3"},{"name":"COVID-19 Vaccine 2","genericName":"COVID-19 Vaccine 2","slug":"covid-19-vaccine-2","indication":"Other","status":"phase_1"},{"name":"Fluzone HD","genericName":"Fluzone HD","slug":"fluzone-hd","indication":"Other","status":"marketed"},{"name":"Influsplit® Tetra","genericName":"Influsplit® Tetra","slug":"influsplit-tetra","indication":"Seasonal influenza prevention (quadrivalent coverage)","status":"phase_3"},{"name":"Moderna mRNA1273.222 Booster","genericName":"Moderna mRNA1273.222 Booster","slug":"moderna-mrna1273-222-booster","indication":"Other","status":"phase_2"},{"name":"VAL-181388","genericName":"VAL-181388","slug":"val-181388","indication":"Other","status":"phase_1"},{"name":"VAL-339851","genericName":"VAL-339851","slug":"val-339851","indication":"Other","status":"phase_1"},{"name":"VAL-506440","genericName":"VAL-506440","slug":"val-506440","indication":"Other","status":"phase_1"},{"name":"mRNA-1010.6","genericName":"mRNA-1010.6","slug":"mrna-1010-6","indication":"Other","status":"phase_2"},{"name":"mRNA-1011.1","genericName":"mRNA-1011.1","slug":"mrna-1011-1","indication":"Other","status":"phase_1"},{"name":"mRNA-1012.1","genericName":"mRNA-1012.1","slug":"mrna-1012-1","indication":"Other","status":"phase_1"},{"name":"mRNA-1018 for H5 Only","genericName":"mRNA-1018 for H5 Only","slug":"mrna-1018-for-h5-only","indication":"Other","status":"phase_1"},{"name":"mRNA-1018 for H7N9","genericName":"mRNA-1018 for H7N9","slug":"mrna-1018-for-h7n9","indication":"Other","status":"phase_1"},{"name":"mRNA-1020","genericName":"mRNA-1020","slug":"mrna-1020","indication":"Other","status":"phase_1"},{"name":"mRNA-1045","genericName":"mRNA-1045","slug":"mrna-1045","indication":"Other","status":"phase_2"},{"name":"mRNA-1083","genericName":"mRNA-1083","slug":"mrna-1083","indication":"Treatment of muscle-wasting diseases such as inclusion body myositis","status":"phase_3"},{"name":"mRNA-1083 Composition 1 Dose A Lot B","genericName":"mRNA-1083 Composition 1 Dose A Lot B","slug":"mrna-1083-composition-1-dose-a-lot-b","indication":"Other","status":"phase_2"},{"name":"mRNA-1083 Composition 2 Dose A","genericName":"mRNA-1083 Composition 2 Dose A","slug":"mrna-1083-composition-2-dose-a","indication":"Other","status":"phase_2"},{"name":"mRNA-1083 Composition 2 Dose B","genericName":"mRNA-1083 Composition 2 Dose B","slug":"mrna-1083-composition-2-dose-b","indication":"Other","status":"phase_2"},{"name":"mRNA-1083.1","genericName":"mRNA-1083.1","slug":"mrna-1083-1","indication":"Other","status":"phase_1"},{"name":"mRNA-1083.2","genericName":"mRNA-1083.2","slug":"mrna-1083-2","indication":"Other","status":"phase_1"},{"name":"mRNA-1083.3","genericName":"mRNA-1083.3","slug":"mrna-1083-3","indication":"Other","status":"phase_1"},{"name":"mRNA-1273.712","genericName":"mRNA-1273.712","slug":"mrna-1273-712","indication":"Other","status":"marketed"},{"name":"mRNA-1405","genericName":"mRNA-1405","slug":"mrna-1405","indication":"Other","status":"phase_1"},{"name":"mRNA-1468","genericName":"mRNA-1468","slug":"mrna-1468","indication":"Other","status":"phase_1"},{"name":"mRNA-1608","genericName":"mRNA-1608","slug":"mrna-1608","indication":"Other","status":"phase_1"},{"name":"mRNA-1653","genericName":"mRNA-1653","slug":"mrna-1653","indication":"Other","status":"phase_1"},{"name":"mRNA-1944","genericName":"mRNA-1944","slug":"mrna-1944","indication":"Other","status":"phase_1"},{"name":"mRNA-1975","genericName":"mRNA-1975","slug":"mrna-1975","indication":"Other","status":"phase_1"},{"name":"mRNA-1982","genericName":"mRNA-1982","slug":"mrna-1982","indication":"Other","status":"phase_1"},{"name":"mRNA-3927","genericName":"mRNA-3927","slug":"mrna-3927","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"immunology","drugs":[{"name":"Investigational mRNA-1273.815","genericName":"Investigational mRNA-1273.815","slug":"investigational-mrna-1273-815","indication":"COVID-19 prevention (variant-updated formulation)","status":"phase_3"},{"name":"mRNA-1345","genericName":"mRNA-1345","slug":"mrna-1345","indication":"Prevention of COVID-19 disease","status":"phase_3"},{"name":"Biological: mRNA-1273","genericName":"Biological: mRNA-1273","slug":"biological-mrna-1273","indication":"COVID-19 prevention","status":"phase_2"},{"name":"Licensed Spikevax Vaccine","genericName":"Licensed Spikevax Vaccine","slug":"licensed-spikevax-vaccine","indication":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus (primary series and booster doses)","status":"phase_3"},{"name":"mRNA-1273 Variant-containing Formulation","genericName":"mRNA-1273 Variant-containing Formulation","slug":"mrna-1273-variant-containing-formulation","indication":"COVID-19 prevention (variant-containing booster formulation)","status":"marketed"},{"name":"mRNA-1283.222","genericName":"mRNA-1283.222","slug":"mrna-1283-222","indication":"COVID-19","status":"phase_3"},{"name":"mRNA-1283.815","genericName":"mRNA-1283.815","slug":"mrna-1283-815","indication":"COVID-19","status":"phase_3"},{"name":"mRNA-1403","genericName":"mRNA-1403","slug":"mrna-1403","indication":"COVID-19 prevention","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"mRNA-1010","genericName":"mRNA-1010","slug":"mrna-1010","indication":"Melanoma (adjuvant setting, in combination with Merck's Keytruda)","status":"phase_3"},{"name":"mRNA-1283","genericName":"mRNA-1283","slug":"mrna-1283","indication":"HPV16/18-positive cervical cancer (in combination with Merck's Keytruda)","status":"marketed"}]}],"pipeline":[{"name":"Fluarix Quadrivalent","genericName":"Fluarix Quadrivalent","slug":"fluarix-quadrivalent","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Influenza Vaccine 2","genericName":"Influenza Vaccine 2","slug":"influenza-vaccine-2","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"SoC Treatment","genericName":"SoC Treatment","slug":"soc-treatment","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Adjuvanted Quadrivalent Influenza Vaccine","genericName":"Adjuvanted Quadrivalent Influenza Vaccine","slug":"adjuvanted-quadrivalent-influenza-vaccine","phase":"phase_2","mechanism":"This vaccine induces an immune response against multiple strains of influenza.","indications":["Prevention of influenza disease caused by four different strains of the influenza virus"],"catalyst":""},{"name":"Afluria® Quadrivalent","genericName":"Afluria® Quadrivalent","slug":"afluria-quadrivalent","phase":"phase_3","mechanism":"Afluria Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and children ≥6 months of age"],"catalyst":""},{"name":"Egg-based Quadrivalent Influenza Vaccine","genericName":"Egg-based Quadrivalent Influenza Vaccine","slug":"egg-based-quadrivalent-influenza-vaccine","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Influenza Vaccine 1","genericName":"Influenza Vaccine 1","slug":"influenza-vaccine-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Investigational COVID-19 Vaccine 2","genericName":"Investigational COVID-19 Vaccine 2","slug":"investigational-covid-19-vaccine-2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Investigational COVID-19 Vaccine Lot A","genericName":"Investigational COVID-19 Vaccine Lot A","slug":"investigational-covid-19-vaccine-lot-a","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Investigational COVID-19 Vaccine Lot B","genericName":"Investigational COVID-19 Vaccine Lot B","slug":"investigational-covid-19-vaccine-lot-b","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Investigational Influenza Vaccine 1","genericName":"Investigational Influenza Vaccine 1","slug":"investigational-influenza-vaccine-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Investigational mRNA-1273.815","genericName":"Investigational mRNA-1273.815","slug":"investigational-mrna-1273-815","phase":"phase_3","mechanism":"mRNA-1273.815 is an mRNA vaccine encoding modified spike proteins designed to elicit immune responses against SARS-CoV-2 variants.","indications":["COVID-19 prevention (variant-updated formulation)"],"catalyst":""},{"name":"SPIKEVAX X","genericName":"SPIKEVAX X","slug":"spikevax-x","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1010","genericName":"mRNA-1010","slug":"mrna-1010","phase":"phase_3","mechanism":"mRNA-1010 is a therapeutic cancer vaccine that encodes personalized tumor-associated neoantigens to stimulate the patient's immune system to recognize and attack cancer cells.","indications":["Melanoma (adjuvant setting, in combination with Merck's Keytruda)","Non-small cell lung cancer (adjuvant setting, in combination with checkpoint inhibitor)"],"catalyst":""},{"name":"mRNA-1018 for H5N8","genericName":"mRNA-1018 for H5N8","slug":"mrna-1018-for-h5n8","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1018 for H7 Only","genericName":"mRNA-1018 for H7 Only","slug":"mrna-1018-for-h7-only","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083 Composition 1 Dose C","genericName":"mRNA-1083 Composition 1 Dose C","slug":"mrna-1083-composition-1-dose-c","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1195","genericName":"mRNA-1195","slug":"mrna-1195","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1273.231","genericName":"mRNA-1273.231","slug":"mrna-1273-231","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1345","genericName":"mRNA-1345","slug":"mrna-1345","phase":"phase_3","mechanism":"mRNA-1345 is an mRNA-based vaccine designed to prevent COVID-19 infection by inducing an immune response against the SARS-CoV-2 virus.","indications":["Prevention of COVID-19 disease"],"catalyst":""},{"name":"mRNA-1647","genericName":"mRNA-1647","slug":"mrna-1647","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1769","genericName":"mRNA-1769","slug":"mrna-1769","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-2752","genericName":"mRNA-2752","slug":"mrna-2752","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Alpharix® Tetra","genericName":"Alpharix® Tetra","slug":"alpharix-tetra","phase":"phase_3","mechanism":"Alpharix Tetra is a multivalent mRNA vaccine designed to stimulate immune responses against multiple disease targets simultaneously.","indications":["Indication under investigation in Phase 3 (specific indication not publicly disclosed)"],"catalyst":""},{"name":"Biological: mRNA-1273","genericName":"Biological: mRNA-1273","slug":"biological-mrna-1273","phase":"phase_2","mechanism":"mRNA-based vaccine that encodes for the SARS-CoV-2 spike protein","indications":["COVID-19 prevention"],"catalyst":""},{"name":"COVID-19 Vaccine 2","genericName":"COVID-19 Vaccine 2","slug":"covid-19-vaccine-2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Fluzone HD","genericName":"Fluzone HD","slug":"fluzone-hd","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Influsplit® Tetra","genericName":"Influsplit® Tetra","slug":"influsplit-tetra","phase":"phase_3","mechanism":"Influsplit® Tetra is a quadrivalent mRNA vaccine that encodes influenza virus surface antigens to stimulate immune responses against four strains of influenza.","indications":["Seasonal influenza prevention (quadrivalent coverage)"],"catalyst":""},{"name":"Licensed Spikevax Vaccine","genericName":"Licensed Spikevax Vaccine","slug":"licensed-spikevax-vaccine","phase":"phase_3","mechanism":"Spikevax is an mRNA vaccine that instructs cells to produce the SARS-CoV-2 spike protein, triggering an immune response to protect against COVID-19 infection.","indications":["Prevention of COVID-19 disease caused by SARS-CoV-2 virus (primary series and booster doses)"],"catalyst":""},{"name":"Moderna mRNA1273.222 Booster","genericName":"Moderna mRNA1273.222 Booster","slug":"moderna-mrna1273-222-booster","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"VAL-181388","genericName":"VAL-181388","slug":"val-181388","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"VAL-339851","genericName":"VAL-339851","slug":"val-339851","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"VAL-506440","genericName":"VAL-506440","slug":"val-506440","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1010.6","genericName":"mRNA-1010.6","slug":"mrna-1010-6","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1011.1","genericName":"mRNA-1011.1","slug":"mrna-1011-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1012.1","genericName":"mRNA-1012.1","slug":"mrna-1012-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1018 for H5 Only","genericName":"mRNA-1018 for H5 Only","slug":"mrna-1018-for-h5-only","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1018 for H7N9","genericName":"mRNA-1018 for H7N9","slug":"mrna-1018-for-h7n9","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1020","genericName":"mRNA-1020","slug":"mrna-1020","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1045","genericName":"mRNA-1045","slug":"mrna-1045","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083","genericName":"mRNA-1083","slug":"mrna-1083","phase":"phase_3","mechanism":"mRNA-1083 encodes an optimized full-length human myostatin propeptide to inhibit myostatin activity and promote muscle growth.","indications":["Treatment of muscle-wasting diseases such as inclusion body myositis"],"catalyst":""},{"name":"mRNA-1083 Composition 1 Dose A Lot B","genericName":"mRNA-1083 Composition 1 Dose A Lot B","slug":"mrna-1083-composition-1-dose-a-lot-b","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083 Composition 2 Dose A","genericName":"mRNA-1083 Composition 2 Dose A","slug":"mrna-1083-composition-2-dose-a","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083 Composition 2 Dose B","genericName":"mRNA-1083 Composition 2 Dose B","slug":"mrna-1083-composition-2-dose-b","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083.1","genericName":"mRNA-1083.1","slug":"mrna-1083-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083.2","genericName":"mRNA-1083.2","slug":"mrna-1083-2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1083.3","genericName":"mRNA-1083.3","slug":"mrna-1083-3","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1273 Variant-containing Formulation","genericName":"mRNA-1273 Variant-containing Formulation","slug":"mrna-1273-variant-containing-formulation","phase":"marketed","mechanism":"mRNA-1273 Variant-containing Formulation encodes instructions for cells to produce spike proteins from SARS-CoV-2 variants, triggering an immune response against those variants.","indications":["COVID-19 prevention (variant-containing booster formulation)"],"catalyst":""},{"name":"mRNA-1273.712","genericName":"mRNA-1273.712","slug":"mrna-1273-712","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1283","genericName":"mRNA-1283","slug":"mrna-1283","phase":"marketed","mechanism":"mRNA-1283 is a self-amplifying mRNA vaccine that encodes human papillomavirus (HPV) antigens to stimulate immune responses against HPV-infected cells.","indications":["HPV16/18-positive cervical cancer (in combination with Merck's Keytruda)","HPV-related cancers and precancerous lesions"],"catalyst":""},{"name":"mRNA-1283.222","genericName":"mRNA-1283.222","slug":"mrna-1283-222","phase":"phase_3","mechanism":"mRNA-1283.222 is a messenger RNA-based vaccine that encodes for a specific protein to stimulate an immune response.","indications":["COVID-19"],"catalyst":""},{"name":"mRNA-1283.815","genericName":"mRNA-1283.815","slug":"mrna-1283-815","phase":"phase_3","mechanism":"mRNA-1283.815 is a messenger RNA-based vaccine that encodes for a specific protein to stimulate an immune response.","indications":["COVID-19"],"catalyst":""},{"name":"mRNA-1403","genericName":"mRNA-1403","slug":"mrna-1403","phase":"phase_3","mechanism":"mRNA-1403 is an mRNA-based vaccine designed to encode for the SARS-CoV-2 spike protein.","indications":["COVID-19 prevention"],"catalyst":""},{"name":"mRNA-1405","genericName":"mRNA-1405","slug":"mrna-1405","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1468","genericName":"mRNA-1468","slug":"mrna-1468","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1608","genericName":"mRNA-1608","slug":"mrna-1608","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1653","genericName":"mRNA-1653","slug":"mrna-1653","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1944","genericName":"mRNA-1944","slug":"mrna-1944","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1975","genericName":"mRNA-1975","slug":"mrna-1975","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-1982","genericName":"mRNA-1982","slug":"mrna-1982","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mRNA-3927","genericName":"mRNA-3927","slug":"mrna-3927","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9wWURXRkdkRl9mdE9QYW1tZThhSndEMTdZYzJ2LWFMbXlyeWtwZmthaEVxbmF1eVVtYms0MUNRUmhsdkV3QWtRRi1NbE43SEdrbG5SeTdraEdNRWNlcUp0RzByVzZpMWVMSTBVR3ln?oc=5","date":"2026-04-03","type":"pipeline","source":"Investopedia","summary":"Top Moderna Shareholders - Investopedia","headline":"Top Moderna Shareholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPLTBmaVJQRkZ6cVhtWXk0dko1T0VjNGYzZUQ0V2dBbVU0SHMxUmtCR1lqdVVqNW1La0xESGJnUjVNdnFOSWMwX1JTaWpXRDBaZWZWd2ROQXNnQnFWTFN2RVdWYVp1aURJM3RXUVhaVnNyQmItSzlFWlZmUXFXUmxGT190MUFxQjM5TmFMNmpoekxUaGFsV0NJVzNQRGpHWWNBT1E?oc=5","date":"2026-03-04","type":"pipeline","source":"Contract Pharma","summary":"Moderna Resolves Worldwide Arbutus/Genevant Litigation - Contract Pharma","headline":"Moderna Resolves Worldwide Arbutus/Genevant Litigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQMy16cHYyTEctVmZWajhYamVaV0ZNVGo5ZVFjVkFVMFMyaVJIRUFKTmxRMFZEMTJrWFdxMnZCQzJLcHlGWjhwM2JCUjR1ZFZ2dllCMDY5cGdaWVlqVHNsS2EzOVcxblkzTlJ2VDNGNmhSM29kMTVMSDlVYlBJMy1xODl3VGdpVmV1Y25mZGt6MzVHaVdhOU9pTU1ZZWRwWm9z?oc=5","date":"2026-02-19","type":"regulatory","source":"Pharma Voice","summary":"Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off. - Pharma Voice","headline":"Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOanVJLWFJOGxkV3FvbzdMR0RUYUFoS3dCa2NvZktZMV8xa09URC1tWkVyekI2Zk8xV21iX1ZUTl9VekNiRHJnVUZ3MXRQZWM4V29UUHo0eXdaelJnLUpXY3Fpc3Y2eWRQdUFkTEJQTkdybGluLTNLcFhoSnVTVThrM1pQRnJIY0J0bkhUNmhsVUdDOHMxVU9xTERZOFpxNEE2cHlfSWRhZFZVY0t5VDY2MVYzeGppS2c?oc=5","date":"2026-02-11","type":"pipeline","source":"Pharmaceutical Technology","summary":"Mexico enlists Moderna to boost mRNA supply for respiratory diseases - Pharmaceutical Technology","headline":"Mexico enlists Moderna to boost mRNA supply for respiratory diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQRzcwRFVSY2h3Si1uQzZmOXFGaWllMUtDbmlqWnBTUE5IUmx1QXpOWlhsWUFsQmh5cDFLOWl4Sld6RGNYQXpLVDVJZk1oUVV4dHRSVHNjUnJqYURlb1ZiQ3hjN2RCdGNWZmFiS0o4R1pQSXhReE84QUd3ZTdqc2ZiWGhB?oc=5","date":"2026-02-04","type":"pipeline","source":"Yahoo Finance","summary":"Jim Cramer on Moderna: “Even Though the Stock’s on the Mend, There Are Many Pharma and Biotech Names That I Like Better” - Yahoo Finance","headline":"Jim Cramer on Moderna: “Even Though the Stock’s on the Mend, There Are Many Pharma and Biotech Names That I Like Better”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOd0w0Q2dIbUlmb2hXNHdSM2hCWDJ6SHFXM0ZlUDBzU1RkeU1PUGE3RlFFMzg4SHBDTWlEYXdWZTkwRDJDWUpUR0dsYjZJYkl5eklFWDdaeUpxZkhDM2FxUXpHbFdqVnVsTmltVll5UjlXeTUxZUlBdG5GVk15MlcwLVdIeHhCVUZvYk80QXNJSlN5cmtKNjd3Nm0zOA?oc=5","date":"2025-12-11","type":"deal","source":"Pharmaceutical Technology","summary":"Moderna signs deal worth up to $503m with Nanexa - Pharmaceutical Technology","headline":"Moderna signs deal worth up to $503m with Nanexa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNMzdtTG9YQl9ydVZ6eTVpZDFZOENOUUoyT2o1QW04dklFd28xVHBQQktkNkNwZWpMQ1lXeThpZEI0RTVDREdXQkotajV2NnZnLVRISEVHVHVIcVY1MkhMUEpmWXY3b19hSXc1WENLbUwwVXA5ekNlVHdRdHRubjFiT2pJdmI4aC1PM2dzYXN0ekZZYkd2dGQ3VG9RS1Y0U2o0S1lyQkJpWDVlUU9rbHJCOHBjMm1janBfcnc?oc=5","date":"2025-11-20","type":"pipeline","source":"Fierce Pharma","summary":"Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028 - Fierce Pharma","headline":"Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGxNeE5uNGw0WDFsNFJvRHBiRTFOQzlTLU1YekVLNVNqeEVjdy1yVHBfVzJEalBDV0J0ODJUcHJPbWt6YzdGSDhYQXp6OXk1dDkzZTBEbnlFbHIwSjdpYTJia0lkbHBoMzdacXdHZ3pNYVI0cjBKdjlobDZ2c2NHMWtfUEM2QlRLQndfLVhYbTBKTlFqeWVYWTRwcEV6VjVYN2ZKamVtT29pUzFqODZhMVN4MDY2UUc4NHl3VTQxS3RTbWQ3UDFZdW5vZklSR2JTbEhIUUpjZVZzODlvaWtv?oc=5","date":"2025-11-19","type":"pipeline","source":"Reuters","summary":"Moderna to complete US mRNA manufacturing network with $140 million investment - Reuters","headline":"Moderna to complete US mRNA manufacturing network with $140 million investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQRVFOYlFGX01JaDBiMWxxZEFFc0NFeVEwVUEyMFk3VjMtcXFBLUd3R0tWQS1NU29KRTlZN2Iwd3FKRWlGYzlKMkFqbGMzRGd6aU9mSHg0cHpvMkFka28tN3d0RVg0WUNKT3NnM00yOXN1MzMwVDdGQkxuNnEySVdCOWVTc1IwT3JwZUJyOGxKaExFWHVUWjY5dFFIbkpPUkU0enVKd1piOV92c2k1QnpmUU15LTFHam40WVR1bEkyVTdEd0JTdl9Yamh3?oc=5","date":"2025-09-25","type":"pipeline","source":"The Guardian","summary":"Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility - The Guardian","headline":"Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQUlM3T3l3QUhYOEVzUkJiM0U3RFdRMllJOUFPeUF4M2paVnhraWhoc1V1Y2RDbHM2NFBNSmVxMGdJR2RHMDNkdUpkSzBjZ3FzemhESGl1MF9SNGZGUHdOTmVDVmlYeUV2TU9VV2l2dU5mRWY1aGlmcU5XcnZRWFEydy1PdUxiUzNZeTh4NFJ1d1FybW1UREJ5d01QZHdjOGhWYUNMQlZVeHBtb3ZfUUZGV1VvUlpScjBsME54Mw?oc=5","date":"2025-09-13","type":"regulatory","source":"Fast Company","summary":"Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths - Fast Company","headline":"Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPMnE0S3gtOVptXzM2cU9tXzZVTXB1MjRpNFZTYTNjclZjSk81OEJRTUlBNWZ0NHRObkVpN0QzRU5keWdxc3p3NENkaGwtT0VGbVpUVVVSeURHQ1JCZ05mdzJJYlF3bVFEVFRTdm5WWmNWT24zbER0TlI5Q2lXQlp6eEkxVEdsbFlGS0NES1gwMDNVd3hzZjFWLUFpY3BPSmRxTkczc1VySGlSU2lv?oc=5","date":"2025-06-04","type":"pipeline","source":"IPWatchdog.com","summary":"CAFC Affirms Moderna’s Win, Holding Alnylam Narrowly Defined ‘Branched Alkyl’ - IPWatchdog.com","headline":"CAFC Affirms Moderna’s Win, Holding Alnylam Narrowly Defined ‘Branched Alkyl’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQRXNKVUhIcExPb3QyZW9HTV9DR0Q5QnlOUjRZWHcxOThYTDIzTnM5MERRMUFVbC1jQnVFY2gxaWRsXzRYQ3VKVUNuUzc0cWFIVFNEUnNyNHRqZWxiTk1jT3dkbllQNldVYkpBN3poZkZFSU1VZDV2bHEybUtwbUtzY1BObHV5UWUzWnYxcVhR?oc=5","date":"2025-05-06","type":"regulatory","source":"Barron's","summary":"Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator - Barron's","headline":"Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator - Barron's","sentiment":"neutral"}],"patents":[],"drugCount":61,"phaseCounts":{"marketed":6,"phase_1":28,"phase_2":15,"phase_3":12},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}